Sales decline 60.30% to Rs 42.90 crore
Net Loss of Parabolic Drugs reported to Rs 39.18 crore in the quarter ended December 2014 as against net loss of Rs 24.46 crore during the previous quarter ended December 2013. Sales declined 60.30% to Rs 42.90 crore in the quarter ended December 2014 as against Rs 108.07 crore during the previous quarter ended December 2013. ParticularsQuarter EndedDec. 2014Dec. 2013% Var.Sales42.90108.07 -60 OPM %-7.041.44 -PBDT-21.99-18.37 -20 PBT-39.18-35.40 -11 NP-39.18-24.46 -60Powered by Capital Market - Live News